• Archives of Pharmacal Research
• /
• 제25권5호
• /
• pp.572-584
• /
• 2002

Rapid development in molecular biology and recent advancement in recombinant technology increase identification and commercialization of potential protein drugs. Traditional forms of administrations for the peptide and protein drugs often rely on their parenteral injection, since the bioavailability of these therapeutic agents is poor when administered nonparenterally. Tremendous efforts by numerous investigators in the world have been put to improve protein formulations and as a result, a few successful formulations have been developed including sustained-release human growth hormone. For a promising protein delivery technology, efficacy and safety are the first requirement to meet. However, these systems still require periodic injection and increase the incidence of patient compliance. The development of an oral dosage form that improves the absorption of peptide and especially protein drugs is the most desirable formulation but one of the greatest challenges in the pharmaceutical field. The major barriers to developing oral formulations for peptides and proteins are metabolic enzymes and impermeable mucosal tissues in the intestine. Furthermore, chemical and conformational instability of protein drugs is not a small issue in protein pharmaceuticals. Conventional pharmaceutical approaches to address these barriers, which have been successful with traditional organic drug molecules, have not been effective for peptide and protein formulations. It is likely that effective oral formulations for peptides and proteins will remain highly compound specific. A number of innovative oral drug delivery approaches have been recently developed, including the drug entrapment within small vesicles or their passage through the intestinal paracellular pathway. This review provides a summary of the novel approaches currently in progress in the protein oral delivery followed by factors affecting protein oral absorption.

• 한국동물위생학회지
• /
• 제16권2호
• /
• pp.103-110
• /
• 1993

The Aeromonas strains were isolated from diseased cultured catfsh (Silurus asotus) in the ponds near by Gochang of Chunbuk. The present isolates were identified as A. hydrophila based on their biological and biochemica1 characteristics. The isolates of A. hydrophila were named GC-1, GC-2, GC-3, GC-4 and GC-5, Five strains were grew optimally at temperatures $35^{\circ}C,$ pH 7.5 and in 0.5 to l% NaCl. This bacterium(GC-1) was injected into health catfish in order to prove the causative agent of ascites and haemorrhagic ulcers. The symptoms in cat fish infected by this challenge method were observed to be very similar to the symptoms of a natural infection, but controls did not show any abnormal symptoms during the experimental period. At 24 post-injection, the red spot developed around the injection site and the haemorrhagic ulcers was extended near the gill and ventral fin. Five strains were tested for drug sensitivity by plate method. All strains were sensitivity to gentamicin and resistant to penicillin, streptomycin and tetracycline.

• Nuclear Engineering and Technology
• /
• 제54권10호
• /
• pp.3949-3956
• /
• 2022

Kori Unit 1 is planning a system decontamination project to reduce radiation exposure of decommissioning workers, prevent the spread of contamination and down-grade the level of classification of radioactive waste. The system decontamination range for Kori Unit 1 will be the entire primary system, including RCS, CVCS and RHRS. Some system design modifications are required for the system decontamination operation. In this paper, major system design modifications were evaluated based on the conditions that system restoration is needed after completion of system decontamination. The major system design modifications are CIDF connection location to system, system decontamination operating pressure control, RCP seal water injection and formation of letdown flow. It was evaluated that there was no negative effect on the system due to the system design modifications. However, as the RCP seal water is injected into the system in the oxidation process, the concentration of the oxidizing agent is diluted. Therefore, the oxidizing agent injection and system decontamination operation procedures should be developed to address the dilution effect of the oxidizing agent. The system design modifications dealt in this paper will be finally confirmed through on-site investigation in the future, and if necessary, the system design modifications will be re-evaluated.

• 대한방사성의약품학회지
• /
• 제7권2호
• /
• pp.113-118
• /
• 2021

Chitosan is a polysaccharide derived from chitin by deacetylation. Chitosan is non-toxic, biodegradable, and biocompatible, so that it can be used in wide variety of medical applications such as wound healing and antimicrobial biomaterials. It also used as dermal fillers due to its ability to inject with liquid formulations. For investigation on in vivo distribution of these chitosans, Bolton-Hunter-conjugated chitosan (Chitosan-BH) was synthesized by the reaction between the primary amino group of chitosan and N-hydroxysuccinimide ester group of Bolton-Hunter reagent. Then Chitosan-BH was radiolabeled with ¹²⁵I (Chitosan-BH-¹²⁵I) using a Chloramine-T method. The effects of each radiolabeling step on the radiolabeling yield of the final product were tested. The results showed that purification step had significant effects on the radiolabeling yield of the final product. Finally, SPECT/CT images were obtained to evaluate in vivo uptake of the radiolabeled chitosan (Chitosan-BH-¹²⁵I) in several organs. The highest uptake was found in the site of injection at 21 days post-injection. The results of this study suggest that chitosan is expected to be useful for biomaterials of dermal fillers.

• 자원환경지질
• /
• 제54권4호
• /
• pp.409-425
• /
• 2021

이산화탄소가 지구온난화를 초래하는 대표적인 온실가스로 지목되면서 대기 중의 이산화탄소 농도를 줄이기 위하여 많은 노력들이 진행되어 왔다. 그러한 노력들 중 특히 CO₂ 포집 및 지중 저장기술(carbon dioxide capture and storage, CCS)이 감축 목표량을 달성하기 위해서 필수적으로 고려되고 있다. 그러나 이러한 지중 저장기술이 상용화되기 위해서는 안전성이 보장되어야 한다. 특히 이산화탄소 누출이 농경지에서 발생할 경우에는 작물 생장과 관련되어 많은 문제를 야기할 수 있다. 이에 본 연구에서는 지중 저장지로부터 누출된 이산화탄소가 토양 비옥도에 미치는 영향에 대하여 고찰하였다. 이를 위하여 인위적인 이산화탄소 누출 시험을 수행하였으며, pH, 양이온치환용량, 교환성 양이온, 전기전도도, 토양 유기물 함량, 총 질소, 질산태 질소, 암모니아태 질소, 총 인, 유효태 인산, 총 황, 유효태 황, 유효태 붕소 등과 같은 토양의 화학적 특성들을 비옥도 지시 인자로 선정하였다. 누출 시험은 비경작지 토양 한 종류와 경작지 토양 두 종류(옥수수와 콩 재배)를 대상으로 이루어졌다. 비경작지 토양은 거친 모래가 많은 사질토양으로 공극률은 42.6%로 조사되었으며, 경작지 토양인 옥수수 재배 토양은 양질 사토(loamy sand)로 공극률이 46.8%이었다. 콩과식물(soybean) 재배 토양은 옥수수 재배 토양과 동일한 양질 사토로서 공극률이 48%로 조사되었다. 누출시험을 위해 6개의 인공누출 칼럼 장치를 이용하여 이산화탄소를 주입하였다. 이산화탄소 주입은 비경작지와 경작지 토양의 경우 각각 60일과 70일 동안 진행하였다. 이산화탄소 누출 후 비경작지 및 경작지 토양에 대하여 각각 12, 14일 간격으로 1 공극 부피의 인공강우 모사 시험을 수행한 후 용출액과 토양 시료를 채취하여 비옥도 지시 인자를 분석하였으며, 이산화탄소 누출 전후 변화 양상을 비교 평가하였다. 토양 내 잔류 교환성 양이온, 전기전도도, 토양 유기물 함량, 총질소, 총인 등은 이산화탄소의 영향을 크게 받지 않은 것으로 나타났다. 그러나 질산태 질소, 암모니아태 질소, 유효 인산, 유효 황, 유효 붕소 등은 감소하는 경향을 보였으며 이에 의해 토양 비옥도를 저하시킬 수 있을 것으로 판단된다. 본 연구에서는 토양의 완충능력 때문에 pH의 변화가 없었지만, 이산화탄소가 장기간 누출된다면 pH의 감소에 의한 토양 산성화가 초래될 가능성이 있을 것으로 예측된다.

• The Korean Journal of Pain
• /
• 제29권2호
• /
• pp.96-102
• /
• 2016

Background: It is widely accepted that cervical interlaminar steroid injection (CIESI) is more effective in treating radicular pain than axial neck pain, but without direct comparison. And the differences of effect after CIESI according to MRI findings are inconsistent. In this retrospective study, we evaluated the therapeutic response of CIESI according to pain sites, durations, MRI findings, and other predictive factors altogether, unlike previous studies, which evaluated them separately. Methods: The medical records of 128 patients who received fluoroscopy guided CIESI were analyzed. We evaluated the therapeutic response (more than a 50% reduction on the visual analog scale [VAS] by their second visit) after CIESI by (1) pain site; neck pain without radicular pain/radicular pain with or without neck pain, (2) pain duration; acute/chronic (more than 6 month), and (3) findings of MRI; herniated intervertebral disc (HIVD)/spinal stenosis, respectively and altogether. Results: Eighty-eight patients (68%) responded to CIESI, and there were no significant differences in demographic data, initial VAS score, or laboratory findings. And there were no significant differences in the response rate relating to pain site, pain duration, or MRI findings, respectively. In additional analysis, acute radicular pain with HIVD patients showed significantly better response than chronic neck pain with spinal stenosis (P = 0.04). Conclusions: We cannot find any sole predictive factor of therapeutic response to the CIESI. But the patients having acute radicular pain with HIVD showed the best response, and those having other chronic neck pain showed the worst response to CIESI.

• Biomolecules & Therapeutics
• /
• 제4권2호
• /
• pp.127-137
• /
• 1996

This study was performed to investigate the toxicity of DA-125 in beagle dogs, an anthracycline antitumor antibiotic. The dogs were administered DA-125 i.v. at 0.0023, 0.0375, 0.15 and 0.6 mg/kg/day, 6 days/week for 26 weeks. At 0.6 mg/kg, all male and female dogs were either sacrificed moribundly or dead during the 26-week treatment. The dogs revealed inactivity, salivation, dark bloody discharge, swelling of the subcutaneous injection site, abscess, and ulceration in the abdominal wall and legs. At 0.15 mg/kg, anorexia, salivation, and swelling of the injection site were observed. The food consumption was decreased with a statistical significance at 6 and 12 weeks treatment in males of 7.6 mg/kg. At 0.0375, 0.15 and 0.6 mg/kg, body weights were decreased significantly in a dose-related fashion after 17 weeks treatment. Total white blood cell counts for male dogs at 0.6 mg/kg were lower than those of control dogs after 13 weeks treatment, which appeared mainly due to decreased neutrophils. At 0.15 mg/kg, testicular atrophy was found in all males by gross pathology and the testicular weights were significantly decreased when compared to those of control males. Microscopically, the testis showed moderate atrophy of the seminiferous tubules and marked decrease in number of spermatozoa in the epididymal tubules. At 0.6 mg/kg, petechia or echymotic hemorrhage was observed in gastrointestinal tract, heart, lungs, and other organs at the necropsy, Marked atrophy of thymus were observed in both males and females. In addition, severe testicular atrophy was noted in all males. Microscopically, gastrointestinal tract showed hemorrhage, epithelial denudation, hypermucus secretion, and atrophy of intestinal villi. Seminiferous tubules of the atrophic testis were lined with Sertoli cells only and devoid of germ cells. Severe oligospermia or aspermia was present in the epididymal tubules. Bone marrow showed marked depletion of hemopoietic cells. In addition, marked atrophy was found in the lymphoid tissue of gastrointestinal tract, various Iymph nodes, and thymus. Injection sites showed marked inflammatory response with necrosis, necrotizing vasculitis, thrombus formation, and ulceration in the skin. According to the present results, no observed effect level appeared to be 0.0375 mg/kg. At 0.15 mg/kg, testis was a target organ, while at 0.6 mg/kg hemopoietic tissue, gastrointestinal tract, and testis were considered to be target organs. At 0.6 mg/kg the test compound seems to inflict a damage on the blood vessels causing hemorrhage in the various organs and tissues.

• 터널과지하공간
• /
• 제33권5호
• /
• pp.348-372
• /
• 2023

고심도 균열암반대수층 환경에서 주로 수행되는 방사성폐기물 처분사업과 관련하여, 부지적합성 및 운영 시 안정성 평가를 평가하는데 있어 해당 대상 부지의 수리지질특성 평가는 필수적이다. 이러한 심부 수리지질 특성평가에 사용되는 인자 자료는 대상 부지에 굴착된 시추공을 이용한 원위치 수리시험을 통해 얻어지는데, 이 때 조사 결과의 정확도와 신뢰성은 적합한 시험방법의 선택, 조사 시스템의 성능, 조사절차의 표준화와 직접적으로 연결된다. 본 보고에서는 심부 암반대수층의 핵심 수리지질 평가인자인 수리전도도와 저류계수를 구하기 위한 대표적인 시험법인 정압주입시험의 상세조사절차를 소개하였다. 본 보고는 2022년도에 제안한 암반공학회 정압주입시험 관련 표준시험법 자료를 보완하여 구체화 하였으며, 본 조사절차가 실제 적용된 화산암 지역 시추공 현장적용 사례도 함께 소개하였다.

• Clinical and Experimental Vaccine Research
• /
• 제13권2호
• /
• pp.155-165
• /
• 2024

Purpose: Pertussis bacteria have many pathogenic and virulent antigens and severe adverse reactions have occurred when using inactivated whole-cell pertussis vaccines. Therefore, inactivated acellular pertussis (aP) vaccines and genetically detoxified recombinant pertussis (rP) vaccines are being developed. The aim of this study was to assess the safety profile of a novel rP vaccine under development in comparison to commercial diphtheria-tetanus-acellular pertussis (DTaP) vaccines. Materials and Methods: The two positive control DTaP vaccines (two- and tri-components aP vaccines) and two experimental recombinant DTaP (rDTaP) vaccine (two- and tri-components aP vaccines adsorbed to either aluminum hydroxide or purified oat beta-glucan) were used. Temperature histamine sensitization test (HIST), indirect Chinese hamster ovary (CHO) cell cluster assay, mouse-weight-gain (MWG) test, leukocytosis promoting (LP) test, and intramuscular inflammatory cytokine assay of the injection site performed for safety assessments. Results: HIST results showed absence of residual pertussis toxin (PTx) in both control and experimental DTaP vaccine groups, whereas in groups immunized with tri-components vaccines, the experimental tri-components rDTaP absorbed to alum showed an ultra-small amount of 0.0066 IU/mL. CHO cell clustering was observed from 4 IU/mL in all groups. LP tests showed that neutrophils and lymphocytes were in the normal range in all groups immunized with the two components vaccine. However, in the tri-components control DTaP vaccine group, as well as two- and tri-components rDTaP with beta-glucan group, a higher monocyte count was observed 3 days after vaccination, although less than 2 times the normal range. In the MWG test, both groups showed changes less than 20% in body temperature and body weight before the after the final immunizations. Inflammatory cytokines within the muscle at the injection site on day 3 after intramuscular injection revealed no significant response in all groups. Conclusion: There were no findings associated with residual PTx, and no significant differences in both local and systemic adverse reactions in the novel rDTaP vaccine compared to existing available DTaP vaccines. The results suggest that the novel rDTaP vaccine is safe.

• The Korean Journal of Pain
• /
• 제12권2호
• /
• pp.171-176
• /
• 1999

Background: Effect of nitric oxide on the hyperalgesia induced by inflammation is controversial. From our previous experiment, NOS inhibitor, L-NAME given during the induction period decrease mechanical hyperalgesia occured by Freund's complete adjuvant induced inflammation. In addition, we attempted to analyze the effects of L-NAME on mechanical hyperalgesia after the development of inflammation by Freund's complete adjuvant in rat paw. Methods: Male Sprague Dawley rats were divided into four groups; control (normal saline), and three different doses of L-NAME (0.1 mg, 1 mg, 10 mg). Inflammation was induced in rats by injecting 0.15 ml of Freund's complete adjuvant (FCA) intraplantarly. Rats showed typical hyperalgesia within twelve hours after injection and maintained this for about one week. Tests were done 2 days after injection of FCA. After the baseline test either L-NAME or saline was injected under light halothane anesthesia. Effect of L-NAME on hyperalgesia was assessed by measuring mechanical hyperalgesia at 15, 30, 60, 90, 120 minutes. Same experients were repeated on normal rats. Results: When injected at the site of inflammation, L-NAME caused dose dependent decrease in mechanical hyperalgesia. However, normal rats also showed increased mechanical threshold after L- NAME injection. Conclusions: Although L-NAME reduces FCA induced mechanical hyperalgesia, this result may solely be due to inhibition of nitric oxide production and need to be further determined.